(0.48%) 5 246.68 points
(0.32%) 39 558 points
(0.75%) 16 511 points
(-1.23%) $78.15
(-1.47%) $2.35
(0.80%) $2 361.80
(1.37%) $28.83
(3.60%) $1 047.15
(-0.23%) $0.924
(-0.03%) $10.81
(-0.26%) $0.794
(-0.28%) $91.34
-4.05% INR 1 357.35
Live Chart Being Loaded With Signals
Cipla Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India, the United States, South Africa, and internationally...
Stats | |
---|---|
Today's Volume | 3.72M |
Average Volume | 1.70M |
Market Cap | 1 095.92B |
EPS | INR0 ( 2024-05-09 ) |
Next earnings date | ( INR10.73 ) 2024-07-24 |
Last Dividend | INR8.50 ( 2023-07-20 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 26.59 |
ATR14 | INR2.00 (0.15%) |
Volume Correlation
Cipla Limited Correlation
10 Most Positive Correlations | |
---|---|
NESCO.NS | 0.972 |
SPENTEX.NS | 0.97 |
PODDARHOUS.NS | 0.967 |
HONAUT.NS | 0.965 |
INSECTICID.NS | 0.963 |
SHAILY.NS | 0.962 |
JINDALPOLY.NS | 0.96 |
AWHCL.NS | 0.957 |
ESTER.NS | 0.957 |
SETUINFRA.NS | 0.957 |
10 Most Negative Correlations | |
---|---|
KIRLFER.NS | -0.948 |
JSLHISAR.NS | -0.937 |
CIGNITITEC.NS | -0.933 |
JINDALSAW.NS | -0.931 |
PGEL.NS | -0.925 |
SONATSOFTW.NS | -0.919 |
KAYNES.NS | -0.918 |
OIL.NS | -0.918 |
ISMTLTD.NS | -0.917 |
CLSEL.NS | -0.916 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cipla Limited Correlation - Currency/Commodity
Cipla Limited Financials
Annual | 2023 |
Revenue: | INR257.74B |
Gross Profit: | INR115.93B (44.98 %) |
EPS: | INR51.05 |
FY | 2023 |
Revenue: | INR257.74B |
Gross Profit: | INR115.93B (44.98 %) |
EPS: | INR51.05 |
FY | 2022 |
Revenue: | INR224.73B |
Gross Profit: | INR142.21B (63.28 %) |
EPS: | INR34.72 |
FY | 2022 |
Revenue: | INR216.33B |
Gross Profit: | INR124.03B (57.33 %) |
EPS: | INR31.20 |
Financial Reports:
No articles found.
Cipla Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR5.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR8.50 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.0933 | 1997-07-28 |
Last Dividend | INR8.50 | 2023-07-20 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 28 | -- |
Total Paid Out | INR55.50 | -- |
Avg. Dividend % Per Year | 0.41% | -- |
Score | 3.22 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.05 | |
Div. Directional Score | 7.59 | -- |
Year | Amount | Yield |
---|---|---|
1997 | INR0 | 0.00% |
1998 | INR0 | 0.00% |
1999 | INR0 | 0.00% |
2000 | INR0 | 0.00% |
2001 | INR0 | 0.00% |
2002 | INR0 | 0.00% |
2003 | INR0 | 0.00% |
2004 | INR0 | 0.00% |
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR3.00 | 0.51% |
2019 | INR3.00 | 0.57% |
2020 | INR1.000 | 0.21% |
2021 | INR5.00 | 0.61% |
2022 | INR5.00 | 0.54% |
2023 | INR8.50 | 0.79% |
2024 | INR0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
POWERGRID.NS | Dividend Knight | 2023-08-08 | Semi-Annually | 17 | 5.08% | |
JSWSTEEL.NS | Dividend Junior | 2023-07-11 | Annually | 20 | 1.70% | |
DLINKINDIA.NS | Dividend Junior | 2023-08-18 | Annually | 15 | 1.18% | |
AARON.NS | Dividend Junior | 2023-08-28 | Sporadic | 5 | 0.36% | |
SRF.NS | Dividend Knight | 2023-08-01 | Semi-Annually | 21 | 0.25% | |
MPHASIS.NS | Dividend Knight | 2023-07-05 | Annually | 20 | 1.43% | |
HERCULES.NS | Dividend Junior | 2023-08-03 | Annually | 17 | 0.67% | |
BIGBLOC.NS | Dividend Junior | 2023-09-15 | Annually | 9 | 0.25% | |
RBL.NS | Dividend Knight | 2023-07-14 | Annually | 17 | 1.97% | |
KOTAKBANK.NS | Dividend Junior | 2023-08-04 | Annually | 23 | 0.04% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.161 | 1.500 | 6.77 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.126 | 1.200 | 5.80 | 6.96 | [0 - 0.3] |
returnOnEquityTTM | 0.164 | 1.500 | 9.29 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 3.70 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.993 | 0.800 | 2.98 | 2.39 | [0.8 - 2.5] |
cashRatioTTM | 0.167 | 1.500 | -0.184 | -0.277 | [0.2 - 2] |
debtRatioTTM | 0.0102 | -1.500 | 9.83 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 62.32 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 19.38 | 2.00 | 3.54 | 7.08 | [0 - 30] |
freeCashFlowPerShareTTM | 19.38 | 2.00 | 0.312 | 0.623 | [0 - 20] |
debtEquityRatioTTM | 0.0125 | -1.500 | 9.95 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.601 | 1.000 | 3.32 | 3.32 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.219 | 1.000 | 7.61 | 7.61 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 4.68 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.780 | 0.800 | 8.13 | 6.51 | [0.5 - 2] |
Total Score | 10.12 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 27.20 | 1.000 | 7.35 | 0 | [1 - 100] |
returnOnEquityTTM | 0.164 | 2.50 | 9.54 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 19.38 | 2.00 | 3.54 | 0.623 | [0 - 30] |
dividendYielPercentageTTM | 0.612 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 19.38 | 2.00 | 3.54 | 7.08 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 5.88 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0613 | 1.000 | -0.968 | 0 | [0.1 - 0.5] |
Total Score | 5.05 |
Cipla Limited
Cipla Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. It also provides respiratory products, including inhalers and nasal sprays, as well as other respiratory products consists of injectables and biosimilars. Cipla Limited has a licensing agreement with Merck & Co., Inc. for the manufacturing and distribution of Molnupiravir, an investigational oral antiviral drug; a license agreement with Eli Lilly and Company for the manufacture and commercialization of the drug baricitinib for Covid-19 indication; and collaborations with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for the clinical trial of the investigational oral anti-viral drug Molnupiravir. The company was incorporated in 1935 and is headquartered in Mumbai, India.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators